Aprea Therapeutics, Inc. 10-K filing
Filed 2026-03-16 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001104659-26-028068
- Form type
- 10-K
- CIK
- 0001781983
- Primary document
- https://www.sec.gov/Archives/edgar/data/1781983/000110465926028068/apre-20251231x10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aprea Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-13.2M | - | - |
| Net Income | $-12.6M | - | - |
| Eps Basic | -1.93 | - | - |
| Eps Diluted | -1.93 | - | - |
| Cash And Equivalents | $14.6M | - | - |
| Total Assets | $15.9M | - | - |
| Shareholders Equity | $12.4M | - | - |
| Operating Cash Flow | $-12.9M | - | - |
| Capital Expenditures | $15,478 | - | - |